Proteomics Market Analysis

Proteomics Market Analysis

Based on component, the proteomics market is segmented as instruments, consumables, and services. The consumables segment is expected to reach around USD 83.65 billion by 2032. The large share of this segment can be attributed to the availability of a wide range of reagents, kits, strips, and other consumables and their subsequent large-scale adoption during each stage of drug discovery, research, and diagnostic applications. Also, increasing government initiatives to support the field of proteomics and genomics along with the increasing research activities being undertaken in for disease diagnostics is set to propel the market for proteomics in the coming years, which will in turn augment the growth of the consumables segment.
 

Based on technique, the proteomics market is segmented as advanced technique, conventional technique, bioinformatics analysis, and other techniques. The advanced technique segment is further sub-segmented into mass spectrometry, gel-based technique, protein microarrays, and others. This segment is expected to growth at the highest CAGR of 10.7% during the forecast period. The high growth of the segment can be attributed to the wide adoption of mass spectrometry and protein microarrays in the field of clinical research and diagnostics. Furthermore, players operating in this market are engaged in the R&D and launch of various technologically advanced analytical equipment with the growing focus on research being undertaken in the field of omics.
 

Increasing initiatives in cancer research is set to aid the growth of the market in the field of proteomics

Based on application, the proteomics market has been segmented into clinical research and clinical diagnosis segments. In 2022, the clinical research segment accounted for the largest share of 54.6% of the global market. Proteomics-based technologies aid in the identification of protein expression patterns and potential biomarkers that can be used to assess tumor classification, prediction, and prognosis, making it a quintessential tool in cancer research. Also, biomarker research is gaining momentum with the aid of proteomics tools and techniques, leading to biomarket identification of diseases and disease diagnostics. Moreover, the increasing government funding in the fields of drug discovery, disease diagnostics, and therapeutics is also supporting market statistics.
 

Based on end use, the proteomics market has been segmented into pharmaceuticals, academic & research institutes, laboratories, and others. The pharmaceutical and biopharmaceutical companies segment held largest revenue share of the global market in 2022. Rising R&D funding from pharmaceutical & biopharmaceutical companies in the development of novel drugs is anticipated to upsurge the demand for proteomics services. Furthermore, growing elderly population across the globe is anticipated to foster the market size.
 

North America accounted for the largest share of the global proteomics market in 2022. This region is witnessing an increase in investments for the development of structure-based designing of drugs, increasing focus on the development of personalized medicine/therapeutics, rising demand for high-quality research tools, and increasing government funding and research initiatives for omics-based studies. In tandem to these growth factors, the presence of a large number of global players in the region supports market expansion.